Virtual Learning Opportunities!

Virtual Learning Opportunities!

Visit our Staff Training page to register for our upcoming learning opportunities, including our annual fall provider seminars, cultural competency training, and SDS submission portal training.

 

Register Today!

Daily News

Preauthorization Update Effective February 1, 2022 for All Lines of Business Requiring Preauthorization

We would like to share updates regarding preauthorization under our Utilization Management (UM) Program.  

Read more

Cost-Share for COVID-19 Treatment Resumes January 1, 2022

Our commitment to assisting members and providers through the many challenges faced during case surges and hospitalizations guided our business decision to continue the cost-share waiver for COVID-19 treatment for our fully insured members. Some of our self-funded groups also chose to extend the member cost-share waiver. 

Read more

Jubilant Cadista Recalls Losartan

Jubilant Cadista Pharmaceuticals Inc. is conducting a market recall at the wholesale level all quantities of all unexpired lots Losartan Potassium Tablets, USP and Losartan Potassium and Hydrochlorothiazide (HCTZ) Tablets, USP distributed under the Cadista label due to the presence of azido, a potential mutagenic impurity. Azido is considered a mutagen, which is a chemical substance that can cause a change in the DNA of a cell. These mutations may increase the risk of cancer, but the specific risk for this azido impurity to cause cancer in humans is unknown.

Read more
View all news and updates